Literature DB >> 7082645

Thermal behavior of fractionated and unfractionated bovine brain cerebrosides.

W Curatolo.   

Abstract

Bovine brain cerebrosides have been fractionated into 2-hydroxy fatty acid containing cerebrosides (HFA-CER) and nonhydroxy fatty acid containing cerebrosides (NFA-CER). The thermal behavior of NFA-CER, HFA-CER, and unfractionated cerebroside model membranes has been studied by differential scanning calorimetry. When NFA-CER is cooled at rates greater than or equal to 2.5 degrees C/min, subsequent heating runs exhibit metastable behavior: a low enthalpy exotherm is observed at approximately 50 degrees C (delta H = -(1-3) cal/g), followed by a high enthalpy endotherm at 72 degrees C (delta H = 16-17 cal/g). Systematic variation of cooling/heating protocols indicates that NFA-CER possesses two low-temperature states, one metastable and the other stable. Cooling from the liquid-crystalline state results in formation of the metastable low-temperature polymorph I, which must transform into the stable low-temperature polymorph II before the liquid-crystalline state can be reached again. By analogy with recent X-ray studies of synthetic N-palmitoylgalactosylsphingosine [Ruocco, M. J., Atkinson, D., Small, D. M., Skarjune, R. P., Oldfield, E., & Shipley, G. G. (1981) Biochemistry 20, 5957], it is proposed that metastable polymorph I is dehydrated relative to stable polymorph II. HFA-CER displays no metastability and exhibits a reversible thermal transition at approximately 68 degrees C (delta H = 7.3 cal/g). The thermal behavior of unfractionated cerebrosides is similar to that of HFA-CER, exhibiting a single reversible transition at approximately 67 degrees C (delta H = 6.9 cal/g). These results suggest that a function of hydroxy fatty acids in brain cerebrosides may be to prevent metastable dehydration in the cerebroside-rich myelin membrane.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082645     DOI: 10.1021/bi00537a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Bilayer properties of totally synthetic C16:0-lactosyl-ceramide.

Authors:  K Saxena; P Zimmermann; R R Schmidt; G G Shipley
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

Review 2.  The lipoidal permeability barriers of the skin and alimentary tract.

Authors:  W Curatolo
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

3.  Effect of chain unsaturation on the structure and thermotropic properties of galactocerebrosides.

Authors:  R A Reed; G G Shipley
Journal:  Biophys J       Date:  1989-02       Impact factor: 4.033

4.  2H and 13C nuclear magnetic resonance study of N-palmitoylgalactosylsphingosine (cerebroside)/cholesterol bilayers.

Authors:  M J Ruocco; D J Siminovitch; J R Long; S K Das Gupta; R G Griffin
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

5.  Acyl structure regulates galactosylceramide's interfacial interactions.

Authors:  S Ali; J M Smaby; R E Brown
Journal:  Biochemistry       Date:  1993-11-02       Impact factor: 3.162

6.  Bilayer nanotubes and helical ribbons formed by hydrated galactosylceramides: acyl chain and headgroup effects.

Authors:  V S Kulkarni; W H Anderson; R E Brown
Journal:  Biophys J       Date:  1995-11       Impact factor: 4.033

7.  Galactocerebroside-phospholipid interactions in bilayer membranes.

Authors:  M J Ruocco; G G Shipley; E Oldfield
Journal:  Biophys J       Date:  1983-07       Impact factor: 4.033

8.  Phase properties of mixtures of ceramides.

Authors:  C H Han; R Sanftleben; T S Wiedmann
Journal:  Lipids       Date:  1995-02       Impact factor: 1.880

9.  Thermotropic phase properties of the hydroxyceramide/cholesterol system.

Authors:  T S Wiedmann; A Salmon
Journal:  Lipids       Date:  1991-05       Impact factor: 1.880

10.  Interaction of cholesterol with galactocerebroside and galactocerebroside-phosphatidylcholine bilayer membranes.

Authors:  M J Ruocco; G G Shipley
Journal:  Biophys J       Date:  1984-12       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.